Spots Global Cancer Trial Database for tretinoin
Every month we try and update this database with for tretinoin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001) | NCT02842827 | Acute Myeloid L... Myelodysplastic... | bomedemstat tretinoin | 18 Years - | Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) | |
| Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome | NCT00003601 | Melanoma (Skin) | fenretinide tretinoin | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00514293 | Lung Cancer | bexarotene capecitabine carboplatin cisplatin docetaxel tretinoin | 18 Years - | National Cancer Institute (NCI) | |
| Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia | NCT00528450 | Leukemia | arsenic trioxid... idarubicin tretinoin | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00017225 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00514293 | Lung Cancer | bexarotene capecitabine carboplatin cisplatin docetaxel tretinoin | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia | NCT00016159 | Leukemia | filgrastim lintuzumab arsenic trioxid... idarubicin tretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis | NCT02278861 | Actinic Keratos... | Oral isotretino... Tretinoin 0,05%... Sunscreen FPS 6... | 50 Years - 75 Years | Universidade Federal de Goias | |
| Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00005825 | Lung Cancer | cisplatin mitomycin C tretinoin vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream | NCT01349556 | Medication Reac... | Tretinoin | 18 Years - | Johns Hopkins University | |
| A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma | NCT03999684 | Adenoid Cystic ... | Tretinoin | 18 Years - | Dana-Farber Cancer Institute | |
| Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia | NCT01409161 | Acute Promyeloc... | Arsenic Trioxid... Gemtuzumab Ozog... Laboratory Biom... Tretinoin | 10 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | NCT00002658 | Leukemia Neutropenia | filgrastim amsacrine cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia | NCT00276601 | Leukemia | arsenic trioxid... cytarabine daunorubicin hy... mercaptopurine methotrexate tretinoin | 5 Years - 74 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia | NCT00276601 | Leukemia | arsenic trioxid... cytarabine daunorubicin hy... mercaptopurine methotrexate tretinoin | 5 Years - 74 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia | NCT00003934 | Adult Acute Mye... Adult Acute Pro... Childhood Acute... Untreated Adult... Untreated Child... | tretinoin daunorubicin hy... cytarabine mercaptopurine methotrexate arsenic trioxid... | - | National Cancer Institute (NCI) | |
| Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy | NCT01404949 | Acute Promyeloc... | Tretinoin and A... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy | NCT00006220 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | arsenic trioxid... tretinoin | 15 Years - | Washington University School of Medicine | |
| Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome | NCT00003601 | Melanoma (Skin) | fenretinide tretinoin | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Phase II 5-Azacytidine Plus VPA Plus ATRA | NCT00326170 | Myelodysplastic... Acute Myelogeno... | 5-Azacytidine (... Valproic Acid All-Trans Retin... | 3 Years - | M.D. Anderson Cancer Center | |
| Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia | NCT02339740 | Acute Promyeloc... | Arsenic Trioxid... Cytarabine Dexamethasone Idarubicin Laboratory Biom... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... Tretinoin | 12 Months - 21 Years | Children's Oncology Group | |
| Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT01820624 | Adult Acute Meg... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... | tretinoin lithium carbona... laboratory biom... | 18 Years - | Case Comprehensive Cancer Center | |
| Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia | NCT01409161 | Acute Promyeloc... | Arsenic Trioxid... Gemtuzumab Ozog... Laboratory Biom... Tretinoin | 10 Years - | M.D. Anderson Cancer Center | |
| S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia | NCT00492856 | Leukemia | mercaptopurine methotrexate tretinoin | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia | NCT02339740 | Acute Promyeloc... | Arsenic Trioxid... Cytarabine Dexamethasone Idarubicin Laboratory Biom... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... Tretinoin | 12 Months - 21 Years | Children's Oncology Group | |
| Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes | NCT00382200 | Myelodysplastic... | decitabine tretinoin DNA methylation... cytogenetic ana... microarray anal... flow cytometry immunohistochem... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00017225 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome | NCT00003601 | Melanoma (Skin) | fenretinide tretinoin | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis | NCT02278861 | Actinic Keratos... | Oral isotretino... Tretinoin 0,05%... Sunscreen FPS 6... | 50 Years - 75 Years | Universidade Federal de Goias | |
| Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome | NCT00002479 | Lymphoma | tretinoin | 18 Years - | Northwestern University | |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | NCT00002701 | Leukemia | busulfan cyclophosphamid... cytarabine etoposide idarubicin mercaptopurine methotrexate mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... radiation thera... | 16 Years - 74 Years | National Cancer Institute (NCI) | |
| Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia | NCT00016159 | Leukemia | filgrastim lintuzumab arsenic trioxid... idarubicin tretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | NCT00002701 | Leukemia | busulfan cyclophosphamid... cytarabine etoposide idarubicin mercaptopurine methotrexate mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... radiation thera... | 16 Years - 74 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia | NCT00866918 | Childhood Acute... Myeloid Neoplas... | Arsenic Trioxid... Cytarabine Diagnostic Labo... Idarubicin Mercaptopurine Methotrexate Mitoxantrone Hy... Tretinoin | 2 Years - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia | NCT00276601 | Leukemia | arsenic trioxid... cytarabine daunorubicin hy... mercaptopurine methotrexate tretinoin | 5 Years - 74 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | NCT00002701 | Leukemia | busulfan cyclophosphamid... cytarabine etoposide idarubicin mercaptopurine methotrexate mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... radiation thera... | 16 Years - 74 Years | National Cancer Institute (NCI) | |
| Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia | NCT02339740 | Acute Promyeloc... | Arsenic Trioxid... Cytarabine Dexamethasone Idarubicin Laboratory Biom... Mitoxantrone Hy... Quality-of-Life... Questionnaire A... Tretinoin | 12 Months - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | NCT00002658 | Leukemia Neutropenia | filgrastim amsacrine cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - | National Cancer Institute (NCI) | |
| Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia | NCT00003934 | Adult Acute Mye... Adult Acute Pro... Childhood Acute... Untreated Adult... Untreated Child... | tretinoin daunorubicin hy... cytarabine mercaptopurine methotrexate arsenic trioxid... | - | National Cancer Institute (NCI) | |
| Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy | NCT01404949 | Acute Promyeloc... | Tretinoin and A... | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
